Top

Archives of Osteoporosis

Published in:

Open Access 01-12-2022 | Sarcopenia | Review

Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis

Authors: Jun Watanabe, Akihiro Saitsu, Atsushi Miki, Kazuhiko Kotani, Naohiro Sata

Published in: Archives of Osteoporosis | Issue 1/2022

Abstract

Purpose

Osteopenia typically presents low bone mineral density (BMD) and has recently been reported as a prognostic factor in various cancers. However, the prognostic value of osteopenia in digestive tract cancers remains to be defined. We aimed to review the prognostic value of preoperative osteopenia in patients with digestive cancers.

Methods

Cohort studies evaluating the prognostic value of preoperative osteopenia in digestive cancers (colorectal, esophageal, hepatic, bile duct, and pancreatic cancer) were searched using electronic databases and trial registries. The exposure was defined as low BMD estimated by computed tomography at 11^th thoracic vertebra, while comparator was normal BMD. The primary outcomes were overall survival and recurrence-free survival for osteopenia. Random effect meta-analyses were performed. The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to assess the certainty of evidence.

Results

A total of 11 studies (2230 patients) were included. Osteopenia was an independent risk factor for overall survival (hazard ratio [HR] = 2.02, 95% CI = 1.47 to 2.78; I² = 74%), along with sarcopenia. Osteopenia also predicted poor recurrence-free survival (HR = 1.96, 95% CI = 1.36 to 2.81; I² = 85%). In subgroup analyses, osteopenia predicted prognosis in colorectal, esophageal, hepatic, and bile duct cancers, but not in pancreatic cancer. The certainty of the evidence was low due to inconsistency and publication bias.

Conclusion

Osteopenia may be independently associated with poor prognosis in patients with digestive tract cancer. Further studies are needed to establish the relevance of osteopenia in the operative prognosis of these patients.

Available only for authorised users

Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics, 2021. CA Cancer J Clin 71:7–33. https://doi.org/10.3322/caac.21654CrossRefPubMed

Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS (2019) Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 156:254–272. https://doi.org/10.1053/j.gastro.2018.08.063CrossRefPubMed

Granieri S, Altomare M, Bruno F, Paleino S, Bonomi A, Germini A, Facciorusso A, Fagnani D, Bovo G, Cotsoglou C (2021) Surgical treatment of gastric cancer liver metastases: systematic review and meta-analysis of long-term outcomes and prognostic factors. Crit Rev Oncol Hematol 163:103313. https://doi.org/10.1016/j.critrevonc.2021.103313CrossRefPubMed

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169CrossRefPubMed

Su H, Ruan J, Chen T, Lin E, Shi L (2019) CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging 19:82. https://doi.org/10.1186/s40644-019-0270-0CrossRefPubMedPubMedCentral

Sepúlveda-Loyola W, Phu S, Bani Hassan E, Brennan-Olsen SL, Zanker J, Vogrin S, Conzade R, Kirk B, Al Saedi A, Probst V, Duque G (2020) The joint occurrence of osteoporosis and sarcopenia (osteosarcopenia): definitions and characteristics. J Am Med Dir Assoc 21:220–225. https://doi.org/10.1016/j.jamdaCrossRefPubMed

Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, Sonnenday CJ, Wang SC, Su GL (2016) Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl 22:1092–1098. https://doi.org/10.1002/lt.24458CrossRefPubMedPubMedCentral

Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N (2013) Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med 158:588–595. https://doi.org/10.7326/0003-4819-158-8-201304160-00003CrossRefPubMedPubMedCentral

Pinto EM, Neves JR, Teixeira A, Frada R, Atilano P, Oliveira F, Veigas T, Miranda A (2021) Efficacy of Hounsfield units measured by lumbar computer tomography on bone density assessment: a systematic review. Spine (Phila Pa 1976). https://doi.org/10.1097/BRS.0000000000004211

10.

Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28:2781–2790. https://doi.org/10.1007/s00198-017-4151-8CrossRefPubMed

11.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral

12.

Shapiro CL, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R, Smith S, Edwards BJ, Frank E, Lyman GH, Smith MR, Mhaskar R, Henderson T, Neuner J (2019) Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline. J Clin Oncol 37:2916–2946. https://doi.org/10.1200/JCO.19.01696CrossRefPubMed

13.

Hayden JA, Côté P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144:427–437. https://doi.org/10.7326/0003-4819-144-6-200603210-00010CrossRefPubMed

14.

Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280–286. https://doi.org/10.7326/0003-4819-158-4-201302190-00009CrossRefPubMed

15.

Higgins JPT, Thomas J (2021) Cochrane handbook for systematic reviews of interventions version 6.2, 2021. Cochrane, 2021. Available online: https://training.cochrane.org/handbook/current. Accessed 9 Aug 2021

16.

Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schünemann HJ (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383–394. https://doi.org/10.1016/j.jclinepi.2010.04.026CrossRefPubMed

17.

Liang KH, Zhang P, Lin CL, Wang SC, Hu TH, Yeh CT, Su GL (2020) Morphomic signatures derived from computed tomography predict hepatocellular carcinoma occurrence in cirrhotic patients. Dig Dis Sci 65:2130–2139. https://doi.org/10.1007/s10620-019-05915-wCrossRefPubMed

18.

Chen CW, Tsai HL, Yeh YS, Lin HL, Huang CW, Chen CF, Chang YT, Lou YT, Wang JY (2013) Osteoporosis self-assessment tool for Asians as a simple risk index of identifying a poor prognosis in women surgically treated for colorectal cancer. J Surg Res 181:242–249. https://doi.org/10.1016/j.jss.2012.06.062CrossRefPubMed

19.

Yamada D, Eguchi H, Iwagami Y, Mukai Y, Hashimoto Y, Asaoka T, Noda T, Kawamoto K, Gotoh K, Kobayashi S, Takeda Y, Tanemura M, Mori M, Doki Y (2017) Patients treated with preoperative chemoradiation for pancreatic ductal adenocarcinoma have impaired bone density, a predictor of distant metastasis. Ann Surg Oncol 24:3715–3724. https://doi.org/10.1245/s10434-017-6040-yCrossRefPubMed

20.

Katsube T, Murayama M, Yamaguchi K, Miyaki A, Isohata N, Asaka S, Shiozawa S, Yoshimatsu K, Shimakawa T, Naritaka Y, Ogawa K (2011) Preoperative bone mineral density in gastric cancer patients. Hepatogastroenterology 58:1071–1074PubMed

21.

22.

Elliott JA, Casey S, Murphy CF, Docherty NG, Ravi N, Beddy P, Reynolds JV, le Roux CW (2019) Risk factors for loss of bone mineral density after curative esophagectomy. Arch Osteoporos 14:6. https://doi.org/10.1007/s11657-018-0556-zCrossRefPubMed

23.

Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S (2019) Bone mineral density as a risk factor for patients undergoing surgery for hepatocellular carcinoma. World J Surg 43:920–928. https://doi.org/10.1007/s00268-018-4861-xCrossRefPubMed

24.

Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Uozumi R, Yagi S, Uemoto S (2019) Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Clin Nutr 38:2770–2777. https://doi.org/10.1016/j.clnu.2018.12.004CrossRefPubMed

25.

Motomura T, Uchiyama H, Iguchi T, Ninomiya M, Yoshida R, Honboh T, Sadanaga N, Akashi T, Matsuura H (2020) Impact of osteopenia on oncologic outcomes after curative resection for pancreatic cancer. In Vivo 34:3551–3557. https://doi.org/10.21873/invivo.12198CrossRefPubMedPubMedCentral

26.

Sharshar M, Kaido T, Shirai H, Okumura S, Yao S, Miyachi Y, Iwamura S, Kamo N, Yagi S, Macshut M, Uemoto S (2020) Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer. Surg Today 50:757–766. https://doi.org/10.1007/s00595-019-01954-yCrossRefPubMed

27.

Toshima T, Yoshizumi T, Kosai-Fujimoto Y, Inokuchi S, Yoshiya S, Takeishi K, Itoh S, Harada N, Ikegami T, Soejima Y, Mori M (2020) Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma. World J Surg 44:258–267. https://doi.org/10.1007/s00268-019-05206-5CrossRefPubMed

28.

Abe K, Furukawa K, Okamoto T, Matsumoto M, Futagawa Y, Haruki K, Shirai Y, Ikegami T (2021) Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer. Int J Clin Oncol. https://doi.org/10.1007/s10147-021-01986-w

29.

Furukawa K, Haruki K, Taniai T, Hamura R, Shirai Y, Yasuda J, Shiozaki H, Onda S, Gocho T, Ikegami T (2021) Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases. Ann Gastroenterol Surg 5:390–398CrossRefPubMedPubMedCentral

30.

Ikuta S, Aihara T, Nakajima T, Kasai M, Yamanaka N (2021) Computed tomography-measured bone mineral density as a surrogate marker of survival after resection of colorectal liver metastases. Ann Transl Med 9(21):10.21037/atm-20-3751

31.

Takahashi K, Nishikawa K, Furukawa K, Tanishima Y, Ishikawa Y, Kurogochi T, Yuda M, Tanaka Y, Matsumoto A, Mitsumori N, Ikegami T (2021) Prognostic significance of preoperative osteopenia in patients undergoing esophagectomy for esophageal cancer. World J Surg 45:3119–3128. https://doi.org/10.1007/s00268-021-06199-wCrossRefPubMed

32.

Tamura S, Ashida R, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ohgi K, Uesaka K (2021) The prognostic impact of skeletal muscle status and bone mineral density for resected distal cholangiocarcinoma. Clin Nutr 40:3552–3558. https://doi.org/10.1016/j.clnu.2020.12.011CrossRefPubMed

33.

Kamada T, Furukawa K, Takahashi J, Nakashima K, Nakaseko Y, Suzuki N, Yoshida M, Ohdaira H, Ikegami T, Suzuki Y (2021) Prognostic significance of osteopenia in patients with colorectal cancer: a retrospective cohort study. Ann Gastroenterol Surg 5:832–843 https://10.1002/ags3.12491CrossRefPubMedPubMedCentral

34.

Sakuma K, Aoi W, Yamaguchi A (2017) Molecular mechanism of sarcopenia and cachexia: recent research advances. Pflugers Arch 469:573–591. https://doi.org/10.1007/s00424-016-1933-3CrossRefPubMed

35.

Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV, Komnenovic V, Kong YY, Schreiber M, Dixon SJ, Sims SM, Khokha R, Wada T, Penninger JM (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440:692–696. https://doi.org/10.1038/nature04524CrossRefPubMed

36.

Zain NM, Seriramulu VP, Chelliah KK (2016) Bone mineral density and breast cancer risk factors among premenopausal and postmenopausal women a systematic review. Asian Pac J Cancer Prev 17:3229–3234PubMed

37.

Stewart A, Kumar V, Torgerson DJ, Fraser WD, Gilbert FJ, Reid DM (2005) Axial BMD, change in BMD and bone turnover do not predict breast cancer incidence in early postmenopausal women. Osteoporos Int 16:1627–1632. https://doi.org/10.1007/s00198-005-1886-4CrossRefPubMed

38.

Narod SA (2011) Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol 8:669–676. https://doi.org/10.1038/nrclinonc.2011.110CrossRefPubMed

39.

Samelson EJ, Christiansen BA, Demissie S, Broe KE, Louie-Gao Q, Cupples LA, Roberts BJ, Manoharam R, D'Agostino J, Lang T, Kiel DP, Bouxsein ML (2012) QCT measures of bone strength at the thoracic and lumbar spine: the Framingham Study. J Bone Miner Res 27:654–663. https://doi.org/10.1002/jbmr.1482CrossRefPubMed

40.

Kiss N, Baguley BJ, Dalla Via J, Fraser SF, Bolam KA, Daly RM (2020) Exercise and nutritional approaches to combat cancer-related bone and muscle loss. Curr Osteoporos Rep 18:291–300. https://doi.org/10.1007/s11914-020-00589-0CrossRefPubMed

41.

Pagnotti GM, Thompson WR, Guise TA, Rubin CT (2021) Suppression of cancer-associated bone loss through dynamic mechanical loading. Bone 150:115998. https://doi.org/10.1016/j.bone.2021.115998CrossRefPubMed

42.

Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51:2375–2390. https://doi.org/10.1249/MSS.0000000000002116CrossRefPubMedPubMedCentral

43.

Lee BL, Lee HS, Jung J, Cho SJ, Chung HY, Kim WH, Jin YW, Kim CS, Nam SY (2005) Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res 11:2518–2525. https://doi.org/10.1158/1078-0432.CCR-04-1282CrossRefPubMed

44.

Furukawa K, Uwagawa T, Haruki K, Fujiwara Y, Iida T, Shiba H, Misawa T, Ohashi T, Yanaga K (2013) Nuclear factor κB activity correlates with the progression and prognosis of pancreatic cancer in a mouse model. Surg Today 43:171–177. https://doi.org/10.1007/s00595-012-0279-5CrossRefPubMed

45.

Casimiro S, Vilhais G, Gomes I, Costa L (2021) The roadmap of RANKL/RANK pathway in cancer. Cells 10:1978. https://doi.org/10.3390/cells10081978CrossRefPubMedPubMedCentral

Title: Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis
Authors: Jun Watanabe
Akihiro Saitsu
Atsushi Miki
Kazuhiko Kotani
Naohiro Sata
Publication date: 01-12-2022
Publisher: Springer London
Keywords: Sarcopenia
Pancreatic Cancer
Pancreatic Cancer
Published in: Archives of Osteoporosis / Issue 1/2022
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-022-01060-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

Physical activity estimated by osteogenic potential and energy expenditure has differing associations with bone mass in young adults: the raine study

An update of the prevalence of osteoporosis, fracture risk factors, and medication use among community-dwelling older adults: results from the Canadian Longitudinal Study on Aging (CLSA)

What is the impact on work of osteoporotic fractures in active patients? A retrospective fracture-liaison-service study—Optiwork 1

The fracture predictive ability of lumbar spine BMD and TBS as calculated based on different combinations of the lumbar spine vertebrae

Anemia is associated with increased risk of non-vertebral osteoporotic fractures in elderly men: the MrOS Sweden cohort

Multidimensional prognostic index and the risk of fractures: an 8-year longitudinal cohort study in the Osteoarthritis Initiative